Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe:exact Study
Günalp Uzun, Alan Bareiß, Matthias Becker, Karina Althaus, Alex Dulovic, Daniel Junker, Katja Schenke-Layland, Peter Martus, Oliver Borst, Nicole Schneiderhan-Marra, Tamam Bakchoul

TL;DR
This study explores factors linked to breakthrough COVID-19 infections in healthcare workers who received three vaccine doses.
Contribution
The study identifies specific health and medication factors associated with breakthrough infections after booster vaccinations in healthcare workers.
Findings
241 out of 629 healthcare workers experienced breakthrough infections during follow-up.
Participants with cardiovascular disease and those taking antihypertensives had lower hazard ratios for breakthrough infections.
Use of analgesics after the first vaccine increased the risk of breakthrough infections.
Abstract
Background: The prevalence of COVID-19 breakthrough infections in healthcare workers (HCWs) remains an issue of concern. This study examines the different characteristics associated with breakthrough infections in HCWs. Methods: From the total participants in the TüSeRe:exact study (n = 1046), we specifically included study participants who had received three vaccinations and were not infected prior to the third vaccination. Participants were invited to complete an online questionnaire, which included inquiries about any breakthrough infections they might have experienced. Univariate Cox regression analysis was used to investigate the association between participant characteristics and breakthrough infections. Results: Among 629 HCWs (497 female and 132 male), 241 (38%) experienced breakthrough infections during the follow-up period. The frequency of breakthrough infections was 39.2%…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · COVID-19 and Mental Health · COVID-19 epidemiological studies
